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ABSTRACT
Objective: This study aimed to evaluate the effectiveness of counseling and the use of a medication booklet on the level of treatment compliance 
through reduced levels of glycated hemoglobin (HbA1C) and Morisky Medication Adherence Scale (MMAS-8) scores in patients with type 2 diabetes 
mellitus.
Methods: This pre-experimental prospectively study was conducted at Dr. Adjidarmo General Hospital, KabupatenLebak, Banten Province, Indonesia. 
The study sample consisted of 30 type 2 diabetic patients who met the inclusion and exclusion criteria and who underwent a counseling intervention 
session and received a medication booklet. Compliance was measured against the MMAS-8 scores and HbA1C levels before the intervention and after 
10 weeks of administration of counseling and receipt of the booklet).
Results: The MMAS-8 scores before and after the intervention were 2.63±1.50 and 0.7±1.18, respectively. The HbA1C levels before and after the 
intervention were 11.31±2.95 and 8.12±2.79, respectively. The measurement results for MMAS-8 and HbA1C were analyzed using the Wilcoxon test.
Conclusions: The analysis showed a significant difference (p<0.001) between the HbA1Cvalues and MMAS-8 scores before and after the intervention. 
Therefore, this study’s finding indicate that the provision of counseling and an informational booklet can improve type 2 diabetes mellitus patient 
compliance with treatment.
Keywords: Morisky Medication Adherence Scale, Glycated hemoglobin, Compliance, Blood glucose, Type 2 diabetes mellitus, Counseling, Medication 
booklet.
INTRODUCTION
The incidence of diabetes mellitus is increasing every year, worldwide. 
In 2013, as many as 382 million people around the world were reported 
to have diabetes mellitus [1]. Indonesia is ranked 7th in the world for 
diabetes mellitus [2]. The national prevalence of diabetes mellitus in 
Indonesia is also increasing, as reported by the National Basic Health 
Survey in 2007 and 2013. The prevalence in 2007 was 1.1%, and the 
prevalence in 2013 was 2.1% [3,4]. Diabetes mellitus is a chronic 
metabolic disease that requires long-term treatment and often a 
complex medication regimen; thus, compliance is a necessity. In 2003, 
the World Health Organization (WHO) reported that the mean value 
of patients’ compliance to long-term therapy for chronic disease in 
developed countries was only 50%, and it was even lower in developing 
countries [5].
The lack of compliance toward diabetes mellitus therapy could lead 
to chronic complications, including macrovascular and microvascular 
complications. Inappropriate disease management and the lack of 
compliance toward diabetes treatment recommendations will also 
reduce the effectiveness of treatment [6,7]. One of the attempts to 
increase patients’ compliance toward treatment is to provide them 
with counseling and a medication booklet. When patients receive new 
knowledge, they are more apt to change their behavior and lifestyle. 
These changes could eventually increase their compliance to their 
ongoing treatment [8].
Glycosylated hemoglobin, known as the glycohemoglobin test (A1C), 
is the examination used to evaluate the effect of therapy changes in 
comparison to baseline values obtained 8-12 weeks before treatment. 
A glycated hemoglobin (HbA1C) examination could be used to manage 
a patient’s average blood sugar level every 3 months, to observe the 
effectiveness of the therapy being administered, and to determine the 
next type of therapy that is required. A high level of HbA1C indicates a 
patient’s lack of compliance in managing his/her blood glucose level. 
The United Kingdom Diabetes Study (UKPDS) reported that a 1% 
reduction in HbA1C could reduce the complication risk by as much as 
21%; it could decrease the number of deaths caused by diabetes by as 
much as 21% and the incidence of myocardial infarction by as much 
as 14% [2,9]. The compliance of diabetes mellitus type 2 patients was 
calculated by measuring the HbA1C level before and after counseling and 
the distribution of a medication booklet. High compliance is shown by 
a low level of HbA1C.
In addition to measuring the level of HbA1C, the level of compliance 
to ongoing treatment of type 2 diabetes mellitus patients can also be 
measured using the Morisky Medication Adherence Scale (MMAS)-
8 questionnaire. The MMAS-8 questionnaire is an assessment tool 
from the WHO that has been validated and frequently used to assess 
the level of patient compliance in chronic diseases, such as diabetes 
mellitus [10]. In the present study, a treatment questionnaire, the 
MMAS-8 questionnaire, and HbA1C levels were used to determine the 
patients’ compliance level. Dr. Adjidarmo General Hospital is the only 
hospital owned by the government of Lebak District in Indonesia. Lebak 
District is the largest district in Banten Province; thus, it is expected 
to be capable of representing the research population. This research 
aimed to assess the effect of counseling and an informational booklet 
on type 2 diabetes mellitus patients at Dr. Adjidarmo General Hospital.
METHODS
This research study used a prospective pre-experiment design. All 
the participants were placed into one group and were provided with 
counseling and an informational booklet; thus, the study utilized a one 
group pre- and post-test group design [11]. In this research study, the 
sample was restricted to a total of 30 people. During the preliminary 
stage of this research (pre-test), the respondents were given the MMAS-
8 questionnaire and a treatment questionnaire, and their HbA1C level 
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was measured to determine their level of treatment compliance. The 
questionnaires’ data were obtained by means of interviews. Afterward, 
the researcher conducted 30-minute counseling sessions with the 
patients and provided them with an informational booklet. 10 weeks 
later (post-test), the respondent are took the MMAS-8 questionnaire 
and the therapy questionnaire, and their HbA1C level were measured 
again. The researcher conducted an interview to facilitate filling out the 
questionnaires.
This research study was conducted at Dr. Adjidarmo General Hospital, 
Lebak District, Banten Province, Indonesia. Samples were taken using 
consecutive sampling methods. This study assessed the impact that two 
independent variable risks, counseling and an informational booklet, 
had on the dependent variable, compliance with ongoing treatment, 
which can be determined through a reduction in the HbA1C level and the 
MMAS-8 score. It also evaluated the impact of confounding variables, 
such as gender, age, duration of type 2 diabetes mellitus, education, 
occupation, other diseases, the type of oral hypoglycemic medication, 
dose regimen, other medications, side effects, herbal medications, 
directions, diet, smoking, and participation in sports/working out.
The questionnaire that was used in this study had undergone validity 
and reliability testing. Data analysis consisted of univariate and bivariate 
analysis. Univariate analysis was done to obtain the distribution of 
the patient characteristics. Bivariate analysis included Wilcoxon test, 
Spearman’s rank correlation coefficient test, paired t-test, and Fisher’s 
exact test.
RESULTS
Characteristics of the type 2 diabetes mellitus patients
Of the type 2 diabetes mellitus patients at Dr. Adjidarmo General 
Hospital that participated in this study, 77% are female. Based on 
data from the National Basic Health Survey (2013), the prevalence 
of type 2 diabetes mellitus has the tendency to be higher in females 
than males [4]. Research conducted by Mihardja also showed that 
hyperglycemic risk is two times higher in females than males [12].
In terms of age, 67% of all the respondents are over 55. Type 2 
diabetes mellitus is typically diagnosed after the age of 40 [4]. Research 
conducted by Mihardja stated that people ranging in age from 35 to 54 
have a 4.7 times greater risk of hyperglycemia in comparison to people 
ranging in age from 15 to 34; people over the age of 55 have a 5.4 times 
higher risk of hyperglycemia in comparison to people ranging in age 
from 15 to 34 [12].
As many as 63% of the respondents have a low education level, 
ranging from no formal education to a junior high education. The level 
of education affects the incidence of type 2 diabetes mellitus. People 
with a high education level typically have more knowledge regarding 
health; thus, they are more aware of the need to maintain their health. 
As many as 90% of the respondents do not have an occupation; most 
of them are homemakers and most of the male respondents had 
retired. Homemakers do not necessarily have low physical activity; 
they engage in a variety of physical activities such as sweeping, 
cooking, and washing [13]. Sixteen of the 30 respondents (53%) had 
been diagnosed with type 2 diabetes mellitus for <5 years. The WHO 
reported that the duration of diseases has a negative correlation with 
compliance; patients with a longer duration of type 2 diabetes mellitus 
tend to have less compliance to ongoing therapy [5]. This current paper 
is in accordance with research stating that respondents that have had 
type 2 diabetes mellitus for <5 years have a mean HbA1C level of 10.2%, 
whereas respondents that have had type 2 diabetes mellitus for more 
than 5 years have a mean HbA1C level of 12.0%.
Based on this research study’s findings, 83% of the respondents 
have comorbidity. Elderly patients with diabetes increase the risk of 
complications and the risk of comorbidity [1]. Hypertension is the most 
common comorbidity affecting the study’s respondents. Hypertension 
is one of the complications and risk factors of type 2 diabetes mellitus. 
Several factors that affect the complications of this condition are 
genetics, gender, age, and blood sugar level [2].
Twenty-one of the 30 respondents (70%) receive two types of 
oral hypoglycemic medication, and one respondent receives three 
combinations of oral hypoglycemic medication due to rejecting 
insulin injections. The combination of oral hypoglycemic medication 
that is typically used is biguanides (metformin) with sulfonylurea. 
This combination increases the medication’s effectiveness because 
sulfonylurea stimulates the pancreas to secret insulin, enabling 
biguanides to work; thus, several medicine manufacturers have 
marketed this drug combination. The combination of metformin 
with sulfonylurea could reduce blood sugar levels more than a single 
medication, at both a maximum and minimum dosage [14].
This study’s result showed that 93% of the respondents receive more 
than one oral hypoglycemic dosage regimen because most of them are 
taking more than two types of oral hypoglycemic medications. A simple 
dose medication regimen is more acceptable for type 2 diabetes mellitus 
patient than a complex regimen. The result of this research showed 
that 11 of the 30 respondents (37%) inaccurately followed the usage 
direction; 3 of the 11 respondents are incorrectly using acarbose and 9 
of the 11 respondents are incorrectly using glibenclamide, glimepiride, 
and gliquidone. Diabetes medications have different working onsets, 
peaks, mechanisms, and durations; thus, they have different usage 
directions. Patients are usually unaware of these facts; they are 
only aware of the need to take their medication after a meal. Several 
factors lead to mistakes in the directions related to medicine usage, 
including a lack of awareness about the directions due to not reading 
the medication pamphlet; an awareness of the correct directions, but 
the inability to follow the directions due to their complexity, feeling 
troubled by the side effects, and last but not least, being oblivious to 
consistently take the medications.
This study’s result showed that 8 of the 30 respondents (27%) 
experienced side effects. The most common side effect is flatulence. 
This could be due to the use of acarbose; one of the side effects of that 
medication is an increase in the frequency and intensity of flatulence 
(74%), which has a tendency to subside after long-term use [15]. As 
many as 90% of the respondents consume other medicines in addition 
to the oral hypoglycemic medicine prescribed because 86.67% of 
these respondents suffered from other diseases; thus, this increases 
the amount of medicine the respondents are taking. The amount of 
medicine they take is also influenced by the severity of their type 2 
diabetes mellitus and other comorbidities [16].
As many as 57% of the respondents stated that they managed their 
diet. They generally limit their consumption of glucose from sugar 
and carbohydrates (which in this population is rice). The sugar 
consumption suggestion for people with type 2 diabetes mellitus is 2 
tablespoons; this is similar to the recommendation for people without 
diabetes, which is not more than 5% of the total calories per day. For 
type 2 diabetes mellitus patients, the emphasis on nutrition therapy 
focuses on the management of glucose, lipids, and hypertension [17].
This study’s result showed that there were no changes in diet before and 
after the intervention. Only 47% of the respondent admitted to a lack of 
compliance in following the recommended diet. Respondents admitted 
that it is difficult to change their diets since they had been following 
the same one for years. The circumstances that tend to make type 2 
diabetes mellitus patient violate their diet include holidays, parties or 
meals in a restaurant, stress, living alone, and feeling bored. Additional 
reasons for why following a diet is challenging include the habit of 
having a meal away from home (snacking), denial about the disease, a 
lack of understanding of the correlation between diet and the disease, 
incorrect information regarding the correlation between diet and 
disease, and a lack of social support from friends and families [5,18]. 
Only 12 of the 30 respondents (40%) engaged in physical workouts. 
The previous study reported that diabetic patient compliance toward 
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physical activities was 19% [19]. In that study, compliance toward 
working out increased by 10% after the intervention.
In type 2 diabetes mellitus, participating in sports or working out 
plays a major role in controlling a patient’s blood glucose level since 
insulin resistance decreases during workouts, insulin sensitivity 
increases, and membrane permeability to glucose increases. This is 
because when muscles are active, insulin is not needed to incorporate 
glucose into the cell since insulin receptor sensitivity increases; thus, 
glucose incorporation increases up to 7-20 times. This response only 
occurs while working out; it does not have a permanent or long-lasting 
effect. Thus, working out should be done regularly [20,21]. However, in 
patients with uncontrolled type 2 diabetes mellitus, working out will 
increase plasma glucagon and cortisol, which will eventually lead to 
the formation of ketone bodies that can be fatal. To prevent this from 
occurring, it is necessary to test blood glucose levels before and after 
working out.
Results showed that only 20% of the respondents smoked tobacco. 
Their smoking habit did not change even after the intervention. 
Smoking is a risk factor for type 2 diabetes mellitus. A meta-analysis 
reported that the risk of diabetes mellitus in smokers increase by as 
much as 45% compared to non-smokers. The amount of smoke being 
inhaled has also been found to be correlated with an increase in the risk 
of type 2 diabetes mellitus [22].
In general, the respondents in the present study had tried herbal 
medications before participating in this research. However, since they 
did not feel any benefit from the herbal medicines, most of them stopped 
consuming them. During this study, only 4 of the 30 respondents 
(13%) were still consuming herbal medicines. Research conducted by 
the National Basic Health Survey found that 22% of diabetic patients 
consumed herbal medications. Other research found that 31% of 
patients consumed food supplement [23]. The types of herbal plants 
being used in India to lower blood glucose level are: Aloe vera, green 
pare, cinnamon, ginseng, fenugreek, shallot, and garlic. Several of 
these herbal plants in India are in clinical trials to lower blood glucose 
levels [24-27].
Compliance level of type 2 diabetes mellitus patients provided 
with counseling and a booklet based on decreased MMAS-8 scores
At the beginning of the research study, the average MMAS-8 score 
was 2.6±1.5, showing that most of the respondents had a low level of 
compliance. 10 weeks after undergoing counseling and receiving the 
medication booklet, a significant difference was found; at that point, the 
average MMAS-8 score decreased to 0.7±1.18. This shows an increase in 
the level of compliance.
The Wilcoxon test result showed a statistically significant difference 
in the MMAS-8 scores before the intervention and 10 weeks after 
the participants received counseling and the medication booklet 
(p<0.05). This result shows that education in form of counseling 
and an informational booklet can increase the treatment compliance 
of type 2 diabetes mellitus patients. A graphic showing the patient 
compliance level percentage based on MMAS-8 scores before and after 
the participants received counseling and the informational booklet are 
presented in Fig. 1.
Compliance level of type 2 diabetes mellitus patients provided 
with counseling and an informational booklet based on reduction 
in HbA1c levels
At the beginning of the research study, the mean value of the respondents’ 
compliance level based on HbA1C was 11.3±2.95%. Twenty-nine of the 
30 respondents (97%) had an HbA1C level above 7%. After undergoing 
counseling and receiving the informational booklet, the mean value of 
compliance level was 8.1±2.79. The average reduction of HbA1C level 
was 3.19±2.42%. The reduction of the HbA1C level to 8.1±2.79% meant 
that the patient was still in the diabetic category since the normal 
level of HbA1C is <6.5%. This could be because the counseling session 
and the booklets were only given during the 10-week period after the 
initial intervention. The Wilcoxon test was conducted to determine the 
difference between the HbA1C level before the intervention and 10 weeks 
after the participants underwent counseling and received the booklet. 
The result shows that there is a statistically significant difference in the 
HbA1C levels (p<0.05). As shown in Table 1, as many as 28 of the 30 
respondents had a reduction of their HbA1C level; however, the levels of 
19 of the respondents were still in the abnormal category (>6.5) and 9 
had their abnormal HbA1C level reduced to a normal level. The paired 
t-test results shown a statistically significant difference between the 
HbA1C level before the intervention and 10 weeks after the participants 
received counseling and an informational booklet (p=0.001).
Bivariate analysis between ΔHbA1C with anthropometric, 
sociodemographic, clinical, and lifestyle variables
Bivariate analysis was conducted using Fisher’s exact test to examine 
the unpaired categorical scale comparative hypothesis, and the 
expected count was <5 [7]. In the present study, age variables had no 
effect on the compliance level (p=0.540).
Education level and occupation were the sociodemographic variables 
analyzed in the present study. Based on the Fisher’s test result, education 
level and occupation had no impact on the compliance level (p=1.000). 
The following clinical variables were also analyzed: Type 2 diabetes 
mellitus duration, comorbidities, the amount of oral hypoglycemic 
medication, the amount of the dosage regimen, the usage directions, 
and other prescribed medicines. The Fisher’s exact test results showed 
that these clinical variables had no impact on the compliance level 
(p=1.000). The following lifestyle variables were analyzed: Diet, herbal 
medication, smoking, and participating in sports or working out. The 
Fisher’s exact test results showed that these lifestyle variables had no 
impact on the compliance level (p=1.000).
Bivariate analysis of the differences between ΔHbA1C and Δ MMAS-8
A normality test was done to evaluate the HbA1C levels and MMAS-8 
scores. The result showed that both the HbA1C level and the MMAS-8 
data were abnormal. To examine the correlation between the numerical 
correlative hypotheses and the abnormal data distribution, Spearman’s 
Fig. 1: Compliance level graphic based on MMAS-8 scores before 
and after counseling and receiving an informational booklet
Table 1: HbA1C level before the intervention and 10 weeks after 
type 2 diabetes mellitus patients who underwent counseling 
and receiving an informational booklet
HbA1C level Before X±SD After X±SD Delta X±SD
HbA1C level (%) 11.31±2.95 8.12±2.79 3.19±2.42*
MMAS-8 scores 2.63±1.50 0.7±1.18 2±1.2**
X±SD; mean±standard deviation. *p<0.05, **p<0.01
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rank correlation coefficient test was conducted. A positive correlation 
between the HbA1C level and MMAS-8 was found with r=0.432 and 
p=0.001. The r=0.432 value shows that there is enough correlation 
between these two factors since an r value close to 0 represents a weak 
correlation [28]. The p=0.001 result shows that there is a significant 
correlation between the HbA1C level and the MMAS-8 score.
DISCUSSION
The respondents’ compliance level was measured using MMAS-8, the 
WHO assessment tool that has been validated and frequently used 
to assess the compliance level of patients toward their medications. 
The MMAS-8 questionnaire addresses three aspects of patient 
compliance: Obliviousness to the requirements of consuming 
medication, intentionally stopping the medication without the 
medical team noticing, and the ability to continue consuming the 
medicine [29]. Counseling was done meticulously taking into account 
the packaging of the information, the condition of the respondents 
(socioculture), and the time and space in which it occurred [30]. 
The information given to the respondents was adjusted according to 
each patient’s condition; if too much information is given during the 
counseling session, the respondents could become bored. Through the 
counseling, the researcher provided suggestions for how to overcome 
the three aspects addressed in the MMAS-8 questionnaire. The 
researcher gave recommendations to help the respondents remember 
to consume their medication, such as always take the medication with 
you wherever you go, always store a supply of the medication in your 
car, and set an alarm on your mobile phone to remind yourself to 
take the medication. During the counseling session, the importance 
of compliance to taking type 2 diabetes mellitus medications and 
the possible risk of complications were emphasized; moreover, the 
respondents needed to be motivated to maintain their therapeutic 
treatment regime. The disadvantage of the MMAS-8 questionnaire 
is that the respondents’ answers could be subjective; they might not 
necessarily reflect their actual behavior. Before the intervention, as 
many as 54% of the respondents had a low compliance level. Based 
on the results of the interview, some of the reasons for the lack of 
compliance included the inability to obtain the medicine, the amount 
of the oral hypoglycemic medicine was insufficient, fasting, and 
forgetfulness. Some of these reasons are similar to those reported by 
Keban, Mustopa, and Purnomo: Forgetfulness, intentionally not taking 
the medication, unaware of the directions, relying on other people, the 
dose was insufficient, did not receive the medicine, and the medicine 
was too expensive [18].
This study’s result shows that counseling and the informational booklet 
were effective in increasing patient compliance. Research conducted 
by the Diabetes among Latinos Best Practices Trial in 2009 also 
reported a higher reduction of HbA1C levels in the group receiving 
counseling in comparison to the group that only received medication. 
Other research has reported that consultation with a pharmacist at 
every appointment could increase the effectiveness of a blood glucose 
control program [31]. In a review of five studies, Lindenmeyer found 
that educational interventions by a pharmacist could increase diabetic 
patient compliance toward medication [32].
The present study’s results showed also that gender has a weak 
correlation with the reduction of the HbA1C level. This finding is 
in accordance with the research conducted by Adisa, which found 
that males have a tendency to forget to consume their medication, 
which impacts their HbA1C level [33]. Further result, which shows 
significant correlation between the HbA1C level and the MMAS-8 
score, is in accordance with the findings reported by Al-Qazaz, which 
found a statistically significant correlation between HbA1C level and 
MMAS-8 [34]. The result of this present research study shows that 
counseling and the informational booklet for 10 weeks could decrease 
the HbA1C level and increase the compliance level significantly. The 
increase in compliance can be seen from the reduction of the MMAS-
8 score.
CONCLUSION
The improvement in the compliance level of type 2 diabetes mellitus 
patients is shown by the reduction in their HbA1C levels and the 
reduction in their MMAS-8 scores. There is a positive correlation 
between gender and the decrease in the HbA1C level. The reduction of 
HbA1C levels is higher in females than males. Further research with a 
larger number of respondents could be conducted to better represent 
the type 2 diabetes mellitus population. Research covering a longer 
period is also required. In addition, further research comparing a 
control group with an intervention group is needed, and more specific 
research regarding the correlation between gender and the reduction 
in HbA1C level is required.
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